Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Abbott researchers found a high proportion of elite HIV controllers in the Democratic Republic of Congo, which could lead to cure insights.
The trial is evaluating an investigational vaccine from Janssen that may require only one shot.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
Intravenous administration allowed the marginally effective BCG vaccination to work better in monkeys.
Federal researchers describe two paths to a vaccine—and one of them uses high-tech computers to design a vaccine candidate!
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
A machine learning algorithm designed small sets of proteins that boasted the greatest potential to elicit a broad-based immune response.
Scientists merge three antibodies that target almost all strains of HIV.
Anthony S. Fauci, MD, head of the National Institute of Allergy and Infectious Diseases, will be the opening plenary speaker at the XIX Intern...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.